Showing 8,841 - 8,860 results of 100,179 for search '(( 5 non decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.56s Refine Results
  1. 8841
  2. 8842
  3. 8843
  4. 8844
  5. 8845
  6. 8846

    Baseline characteristics. by David Röthlisberger (17684467)

    Published 2023
    “…</p><p>Methods</p><p>We analysed data from the Leiden 85-plus Study, a prospective, population-based cohort study with adults aged ≥85 years and a 5-year follow-up. …”
  7. 8847
  8. 8848

    Data processing and analysis steps. by Alexandra V. Kulinkina (5335058)

    Published 2023
    “…We derived environmental variables from fine-resolution RS data (Landsat 8) and examined a variable distance radius (1–5 km) for aggregating these variables around point-prevalence locations in a non-parametric random forest modeling approach. …”
  9. 8849

    40 anonymized datasets used in the analysis. by Alexandra V. Kulinkina (5335058)

    Published 2023
    “…We derived environmental variables from fine-resolution RS data (Landsat 8) and examined a variable distance radius (1–5 km) for aggregating these variables around point-prevalence locations in a non-parametric random forest modeling approach. …”
  10. 8850

    Summary of analysis variables. by Alexandra V. Kulinkina (5335058)

    Published 2023
    “…We derived environmental variables from fine-resolution RS data (Landsat 8) and examined a variable distance radius (1–5 km) for aggregating these variables around point-prevalence locations in a non-parametric random forest modeling approach. …”
  11. 8851
  12. 8852
  13. 8853
  14. 8854

    Supplementary Material for: Modified Arytenoid Adduction Operation for the Treatment of Unilateral Vocal Fold Paralysis by Liu C. (4120429)

    Published 2021
    “…<b><i>Introduction:</i></b> Unilateral vocal fold paralysis (UVFP) was a relative common glottic insufficiency disease; however, a completely satisfactory treatment of UVFP was elusive. …”
  15. 8855

    Metabolic syndrome network visualizing cardiovascular risk factor burden, clustering, and flow of its components between baseline and five-year follow-up. by Robin Haring (149871)

    Published 2013
    “…<p>“<b>Healthy</b>”, no prevalent metabolic syndrome component; “<b>Obesity</b>”, waist circumference: men <u>></u>94 cm, women <u>></u> 80 cm; “<b>Glucose</b>”, elevated non-fasting glucose: ≥8.0 mmol/l or antidiabetic treatment (anatomic-therapeutical-chemical [ATC] codes A10A, A10B); “<b>HDL</b>”, decreased high-density lipoprotein cholesterol: men <1.0 mmol/l, women <1.3 mmol/l, or lipid-lowering treatment (ATC C10AB, A10AD); “<b>TG</b>”, elevated non-fasting triglycerides: ≥2.3 mmol/l or lipid-lowering treatment (ATC C10AB, A10AD); “<b>BP</b>”, elevated blood pressure: ≥130/85 mmHg or antihypertensive drug treatment. …”
  16. 8856
  17. 8857
  18. 8858
  19. 8859
  20. 8860